| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.613 | 3.578 | 0 | 0 | 0 | 0 | 0 | 0 | 24.260 | 0 |
| Total Income - EUR | 18.613 | 3.578 | 0 | 0 | 0 | 0 | 0 | 0 | 24.260 | 0 |
| Total Expenses - EUR | 11.113 | 3.327 | 541 | 0 | 0 | 0 | 0 | 79 | 18.828 | 1.693 |
| Gross Profit/Loss - EUR | 7.501 | 252 | -541 | 0 | 0 | 0 | 0 | -79 | 5.431 | -1.693 |
| Net Profit/Loss - EUR | 6.338 | 144 | -541 | 0 | 0 | 0 | 0 | -79 | 5.189 | -1.693 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Luxormed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 13.640 | 1.547 | 16 | 16 | 0 | 0 | 0 | 0 | 9.101 | 5.157 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.065 | 0 |
| Cash | 13.640 | 1.547 | 16 | 16 | 0 | 0 | 0 | 0 | 3.036 | 5.157 |
| Shareholders Funds | 12.902 | 189 | -356 | -349 | -342 | -336 | -328 | -409 | 4.781 | 3.061 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 738 | 1.358 | 372 | 365 | 342 | 336 | 328 | 409 | 4.320 | 2.096 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Luxormed Srl